| Exercise, Stress Resistance, and Central Serotonergic Systems. | |
| | |
MedLine Citation:
|
PMID: 21508844 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Voluntary exercise reduces the incidence of stress-related psychiatric disorders in humans and prevents serotonin-dependent behavioral consequences of stress in rodents. Evidence reviewed herein is consistent with the hypothesis that exercise increases stress resistance by producing neuroplasticity at multiple sites of the central serotonergic system which all help to limit the behavioral impact of acute increases in serotonin during stressor exposure. |
| | |
Authors:
|
Benjamin N Greenwood; Monika Fleshner |
Related Documents
:
|
6853914 - Hemodynamic, angiographic and scintigraphic correlates of positive exercise electrocard... 3549364 - Conditioning exercise decreases premenstrual symptoms: a prospective, controlled 6-mont... 11459344 - Magnetocardiographic and electrocardiographic exercise mapping in healthy subjects. 9524014 - Therapeutic benefits of cilazapril in patients with syndrome x. 19058604 - Survival of vibrio cholerae on different finger locations of a volunteer following arti... 16457824 - Avian thyroid development and adaptive plasticity. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-4-19 |
Journal Detail:
|
Title: Exercise and sport sciences reviews Volume: - ISSN: 1538-3008 ISO Abbreviation: - Publication Date: 2011 Apr |
Date Detail:
|
Created Date: 2011-4-21 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0375434 Medline TA: Exerc Sport Sci Rev Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Integrative Physiology and Center for Neuroscience, University of Colorado-Boulder, Boulder, CO 80309-0354. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: New treatment targets in ankylosing spondylitis and other spondyloarthritides.
Next Document: Plasma catecholamine release-inhibitory peptide catestatin in patients with essential hypertension.